Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy

Fig. 2

The prognostic potential of TIMM8A in different cancers. A–L High and low expression of TIMM8A in BRCA, UCEC, CESC, ESCA, HNSC, KIRC, LIHC, LUAD, LUSC, READ, STAD, and BLCA in the Kaplan-Meier plotter database impact on OS. M–O OS, RFS, and DMFS survival curves in three BRCA cohorts [E-TABM-158 (n=117), GSE12276 (n=204), and GSE11121 (n=200)] in the PrognoScan database. P Survival probability in UCEC. OS, overall survival; RFS, recurrence-free survival; DMFS, distant metastasis-free survival (an additional excel file shows this in more detail (see Additional file 1))

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us